BACKGROUND: Modulation of the cardiac autonomic nervous system (ANS) is a promising adjuvant therapy in the treatment of atrial fibrillation (AF). In pre-clinical models, pulsed field (PF) energy has the advantage of selectively ablating the epicardial ganglionated plexi (GP) that govern the ANS. This study aims to demonstrate the feasibility and safety of epicardial ablation of the GPs with PF during cardiac surgery with a primary efficacy outcome of prolongation of the atrial effective refractory period (AERP). METHODS: In a single-arm, prospective analysis, patients with or without a history of AF underwent epicardial GP ablation with PF during coronary artery bypass grafting (CABG). AERP was determined immediately pre- and post- GP ablation to assess cardiac ANS function. Holter monitors were performed to determine rhythm status and heart rate variability (HRV) at baseline and at 1-month post-procedure. RESULTS: Of 24 patients, 23 (96%) received the full ablation protocol. No device-related adverse effects were noted. GP ablation resulted in a 20.7 ± 19.9% extension in AERP (P < 0.001). Post-operative AF was observed in 7 (29%) patients. Holter monitoring demonstrated an increase in mean heart rate (74.0 ± 8.7 vs. 80.6 ± 12.3, P = 0.01). There were no significant changes in HRV. There were no study-related complications. CONCLUSIONS: This study demonstrates the safety and feasibility of epicardial ablation of the GP using PF to modulate the ANS during cardiac surgery. Large, randomized analyses are necessary to determine whether epicardial PF ablation can offer a meaningful impact on the cardiac ANS and reduce AF. TRIAL REGISTRATION: Clinical trial registration: NCT04775264.

AtriAN Medical Galway Ireland

Helmsley Electrophysiology Center Icahn School of Medicine at Mount Sinai Box 1030 One Gustave L Levy Place New York NY 10029 USA

Homolka Hospital Prague Czech Republic

Mayo Clinic Rochester MN USA

Royal Jubilee Hospital Victoria BC Canada

Tbilisi Heart and Vascular Clinic Tbilisi Georgia

University Medical Center Amsterdam The Netherlands

Zobrazit více v PubMed

Kis Z, Muka T, Franco OH, et al. The short and long-term efficacy of pulmonary vein isolation as a sole treatment strategy for paroxysmal atrial fibrillation: a systematic review and meta-analysis. Curr Cardiol Rev. 2017;13:199–208. PubMed DOI PMC

Andrade JG, Champagne J, Dubuc M, et al. Cryoballoon or radiofrequency ablation for atrial fibrillation assessed by continuous monitoring: a randomized clinical trial. Circulation. 2019;140:1779–88. PubMed DOI

Tang LYW, Hawkins NM, Ho K, et al. Autonomic alterations after pulmonary vein isolation in the CIRCA-DOSE (cryoballoon vs irrigated radiofrequency catheter ablation) study. J Am Heart Assoc. 2021;10:e018610. PubMed DOI PMC

Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995;92:1954–68. PubMed DOI

Ravelli F, Allessie M. Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart. Circulation. 1997;96:1686–95. PubMed DOI

Capucci A, Biffi M, Boriani G, et al. Dynamic electrophysiological behavior of human atria during paroxysmal atrial fibrillation. Circulation. 1995;92:1193–202. PubMed DOI

Liu L, Nattel S. Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity. Am J Physiol. 1997;273:H805–16. PubMed

Bayer JD, Boukens BJ, Krul SPJ, et al. Acetylcholine delays atrial activation to facilitate atrial fibrillation. Front Physiol. 2019;10:1105. PubMed DOI PMC

Centurion OA, Isomoto S, Shimizu A. Electrophysiological changes of the atrium in patients with lone paroxysmal atrial fibrillation. J Atr Fibrillation. 2010;3:232. PubMed PMC

Katritsis DG, Giazitzoglou E, Zografos T, Pokushalov E, Po SS, Camm AJ. Rapid pulmonary vein isolation combined with autonomic ganglia modification: a randomized study. Heart Rhythm. 2011;8:672–8. PubMed DOI

Katritsis DG, Pokushalov E, Romanov A, et al. Autonomic denervation added to pulmonary vein isolation for paroxysmal atrial fibrillation: a randomized clinical trial. J Am Coll Cardiol. 2013;62:2318–25. PubMed DOI

Driessen AHG, Berger WR, Krul SPJ, et al. Ganglion plexus ablation in advanced atrial fibrillation: the AFACT study. J Am Coll Cardiol. 2016;68:1155–65. PubMed DOI

Berger WR, Neefs J, van den Berg NWE, et al. Additional Ganglion plexus ablation during thoracoscopic surgical ablation of advanced atrial fibrillation: intermediate follow-up of the AFACT study. JACC Clin Electrophysiol. 2019;5:343–53. PubMed DOI

van Driel VJ, Neven K, van Wessel H, Vink A, Doevendans PA, Wittkampf FH. Low vulnerability of the right phrenic nerve to electroporation ablation. Heart Rhythm. 2015;12:1838–44. PubMed DOI

Cochet H, Nakatani Y, Sridi-Cheniti S, et al. Pulsed field ablation selectively spares the oesophagus during pulmonary vein isolation for atrial fibrillation. Europace. 2021;23:1391–9. PubMed DOI PMC

Musikantow DR, Neuzil P, Petru J, Koruth JS, Kralovec S, Miller MA, Funasako M, Chovanec M, Turagam MK, Whang W, Sediva L, Dukkipati SR, Reddy VY. Pulsed field ablation to treat atrial fibrillation: Autonomic nervous system effects. JACC Clin Electrophysiol 2023;9:481–493.

Stojadinovic P, Wichterle D, Peichl P, et al. Autonomic changes are more durable after radiofrequency than pulsed electric field pulmonary vein ablation. JACC Clin Electrophysiol. 2022;8:895–904. PubMed DOI

Avazzadeh S, O'Brien B, Coffey K, O'Halloran M, Keane D, Quinlan LR. Establishing irreversible electroporation electric field potential threshold in a suspension in vitro model for cardiac and neuronal cells. J Clin Med 2021;10.

Avazzadeh S, Dehkordi MH, Owens P, et al. Establishing electroporation thresholds for targeted cell specific cardiac ablation in a 2D culture model. J Cardiovasc Electrophysiol. 2022;33:2050–61. PubMed DOI PMC

Madhavan M, Venkatachalam KL, Swale MJ, et al. Novel percutaneous epicardial autonomic modulation in the canine for atrial fibrillation: results of an efficacy and safety study. Pacing Clin Electrophysiol. 2016;39:407–17. PubMed DOI PMC

van Zyl M, Khabsa M, Tri JA, et al. Open-chest pulsed electric field ablation of cardiac ganglionated plexi in acute canine models. J Innov Card Rhythm Manag. 2022;13:5061–9. PubMed DOI PMC

Taha A, Nielsen SJ, Bergfeldt L, et al. New-onset atrial fibrillation after coronary artery bypass grafting and long-term outcome: a population-based nationwide study from the SWEDEHEART Registry. J Am Heart Assoc. 2021;10:e017966. PubMed DOI

Demirel S, Tukek T, Akkaya V, Atilgan D, Ozcan M, Guven O. Heart rate variability after coronary artery bypass grafting. Am J Cardiol. 1999;84:496–7. PubMed

Kuo CD, Chen GY, Lai ST, Wang YY, Shih CC, Wang JH. Sequential changes in heart rate variability after coronary artery bypass grafting. Am J Cardiol. 1999;83(776–9):A9. PubMed

Lowres N, Mulcahy G, Jin K, Gallagher R, Neubeck L, Freedman B. Incidence of postoperative atrial fibrillation recurrence in patients discharged in sinus rhythm after cardiac surgery: a systematic review and meta-analysis. Interact Cardiovasc Thorac Surg. 2018;26:504–11. PubMed DOI

Almassi GH, Wagner TH, Carr B, et al. Postoperative atrial fibrillation impacts on costs and one-year clinical outcomes: the Veterans Affairs Randomized On/Off Bypass Trial. Ann Thorac Surg. 2015;99:109–14. PubMed DOI

Bockeria OL, Kanametov TN, Shvartz VA, et al. Epicardial application of hydrogel with amiodarone for prevention of postoperative atrial fibrillation in patients after coronary artery bypass grafting. J Cardiovasc Transl Res. 2020;13:191–8. PubMed DOI

Buckley MS, Nolan PE Jr, Slack MK, Tisdale JE, Hilleman DE, Copeland JG. Amiodarone prophylaxis for atrial fibrillation after cardiac surgery: meta-analysis of dose response and timing of initiation. Pharmacotherapy. 2007;27:360–8. PubMed DOI

Pokushalov E, Kozlov B, Romanov A, et al. Long-term suppression of atrial fibrillation by botulinum toxin injection into epicardial fat pads in patients undergoing cardiac surgery: one-year follow-up of a randomized pilot study. Circ Arrhythm Electrophysiol. 2015;8:1334–41. PubMed DOI

Romanov A, Pokushalov E, Ponomarev D, et al. Long-term suppression of atrial fibrillation by botulinum toxin injection into epicardial fat pads in patients undergoing cardiac surgery: Three-year follow-up of a randomized study. Heart Rhythm. 2019;16:172–7. PubMed DOI

Waldron NH, Cooter M, Haney JC, et al. Temporary autonomic modulation with botulinum toxin type A to reduce atrial fibrillation after cardiac surgery. Heart Rhythm. 2019;16:178–84. PubMed DOI

Wang H, Zhang Y, Xin F, et al. Calcium-induced autonomic denervation in patients with post-operative atrial fibrillation. J Am Coll Cardiol. 2021;77:57–67. PubMed DOI

Zobrazit více v PubMed

ClinicalTrials.gov
NCT04775264